Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CDRH (Center for Devices and Radiological Health) mulls labelling change

This article was originally published in Clinica

Executive Summary

The FDA may rethink its product labelling requirements, according to David Feigal, director of the Center for Devices and Radiological Health. Dr Feigal said at the annual meeting of AdvaMed, the Advanced Medical Technology Association in Palm Springs, California last month (see Clinica No 952, p 11), that the morass of labelling now required as part of a product insert is "an area that is really ripe for change".





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts